Antibody Therapeutics Market Driven by Growing Use in Infectious Disease Treatments Globally

The antibody therapeutics market is expected to grow significantly in the coming years. Its value is projected to rise from US$ 266.9 billion in 2024 to US$ 737.6 billion by 2034, at a CAGR of 10.7% between 2025 and 2034. This growth is driven by increasing cases of chronic diseases, advancements in biotechnology, and rising awareness about precision medicine. Antibody-based therapies are widely used to treat cancer, autoimmune disorders, and infectious diseases, making them a key part of modern healthcare. Cancer treatment is one of the strongest drivers of this market. Monoclonal antibodies, which target specific cancer cells, are widely used because they minimize damage to healthy tissues. Their effectiveness and safety profile are pushing demand across hospitals and specialty clinics. As cancer cases continue to rise, the need for targeted therapies will also grow.